MoneyWorks4Me

Venus Remedies - Quaterly Results

30 May 2024 Evaluate
The March 2024 quarter revenue stood at Rs. 1751.60 millions, up 17.93% as compared to Rs. 1485.30 millions during the corresponding quarter last year.Net profit for the quarter ended March 2024 increased significantly by 65.92% to Rs. 125.10 millions from Rs. 75.40 millions.Operating profit surged to 251.90 millions from the corresponding previous quarter of 242.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1751.60 1485.30 17.93 5752.10 5376.60 6.98 5752.10 5376.60 6.98
Other Income 39.10 32.40 20.68 113.20 101.70 11.31 113.20 101.70 11.31
PBIDT 251.90 242.70 3.79 722.00 717.00 0.70 722.00 717.00 0.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 251.90 242.70 3.79 722.00 717.00 0.70 722.00 717.00 0.70
Depreciation 57.20 80.60 -29.03 255.50 313.70 -18.55 255.50 313.70 -18.55
PBT 194.70 162.10 20.11 466.50 403.30 15.67 466.50 403.30 15.67
TAX 69.60 86.70 -19.72 161.50 113.70 42.04 161.50 113.70 42.04
Deferred Tax 15.80 86.70 -81.78 39.30 113.70 -65.44 39.30 113.70 -65.44
PAT 125.10 75.40 65.92 305.00 289.60 5.32 305.00 289.60 5.32
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 14.38 16.34 -11.99 12.55 13.34 -5.88 12.55 13.34 -5.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..